Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 6/20 | 0.66 |
| ▸ | PLG | P00747 | 16/20 | 0.61 |
| ▸ | PLAU | P00749 | 16/20 | 0.61 |
| ▸ | ST14 | Q9Y5Y6 | 4/20 | 0.60 |
| ▸ | F2 | P00734 | 3/20 | 0.60 |
| ▸ | HPN | P05981 | 1/20 | 0.58 |
| ▸ | HGFAC | Q04756 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6266784 | 0.89 | F10 (0.82) | F10PLGPLAUST14F2 | |
| SCHEMBL28534925 | 0.87 | PLAU (0.73) | F10PLGPLAUST14F2 | |
| SCHEMBL17700973 | 0.87 | PLAU (0.73) | F10PLGPLAUST14F2 | |
| N-(Ethoxycarbonyl)Piperazine SCHEMBL1809303 | 0.86 | PLAU (0.67) | F10PLGPLAUST14F2 | |
| N-(Ethoxycarbonyl)Piperazine SCHEMBL2875164 | 0.85 | PLAU (0.65) | F10PLGPLAUST14F2 | |
| SCHEMBL19922916 | 0.84 | ST14 (0.84) | F10PLGPLAUST14F2 | |
| SCHEMBL19922913 | 0.84 | ST14 (0.84) | F10PLGPLAUST14F2 | |
| Upamostat SCHEMBL12618906 | 0.82 | PLAU (0.84) | F10PLGPLAUST14F2 | |
| Upamostat SCHEMBL20674935 | 0.82 | PLAU (0.84) | F10PLGPLAUST14F2 | |
| Upamostat SCHEMBL30912299 | 0.82 | PLAU (0.84) | F10PLGPLAUST14F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080058346-A1 | Crystalline Modifications of N-Alpha-(2,4,6-Triisopropylphenylsulfonyl)-3-Hydroxyamidino- (L)- Phenylalanine 4-Ethoxycarbonylpiperazide And/Or Salts Thereof | WILEX AG (DE) | 2008-03-06 | — | — | US | claimed |
| CN-117695284-B | Treatment of coronavirus infection | 红山生物医药有限公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-117695284-A | Treatment of coronavirus infection | 红山生物医药有限公司 | 2024-03-15 | — | — | CN | disclosed |
| CN-115515560-B | Treatment of coronavirus infection | 红山生物医药有限公司 | 2023-12-15 | — | — | CN | disclosed |
| CN-115515560-A | Treatment of coronavirus infection | 红山生物医药有限公司 | 2022-12-23 | — | — | CN | disclosed |